Madrigal Pharmaceuticals, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 30/07/2026 | Mar 2026Filed 30/07/2026 | Sep 2025Filed 30/07/2026 | Jun 2025Filed 30/07/2026 | Mar 2025Filed 30/07/2026 | Sep 2024Filed 04/11/2025 | Jun 2024Filed 04/11/2025 | Mar 2024Filed 04/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $364 | $311 | $287 | $213 | $137 | $62 | $15 | $0 | |
| −$58 | −$94 | −$114 | −$42 | −$73 | −$107 | −$152 | −$148 | |
| −$1.99 | −$3.25 | −$4.01 | −$1.50 | −$2.61 | −$4.92 | −$7.10 | −$7.38 | |
| 29 | 29 | 29 | 28 | 28 | 22 | 21 | 20 |
Trend